Reyon Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reyon Pharmaceutical Co Ltd with three other
companies in this sector in South Korea:
Hyundai Pharmaceutical Company Limited
sales of 130.48 billion Korean Won [US$115.21 million]
of which 88%
Kukje Pharma Co Ltd
(123.31 billion Korean Won [US$108.88 million]
of which 92%
was Pharmaceutical), and
Daehwa Pharmaceutical Company Limited
(122.20 billion Korean Won [US$107.90 million]
During the year ended December of 2017, sales at
Reyon Pharmaceutical Co Ltd were 126.25 billion Korean Won (US$111.48 million).
increase of 3.6%
versus 2016, when the company's sales were 121.85 billion Korean Won.
This was the fourth straight year of sales growth at Reyon Pharmaceutical Co Ltd.